Nath Bio-Genes

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
142.45
-3.4 (-2.33%)
BSENSE

Dec 05

BSE+NSE Vol: 59.02 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Net Sales
327.55
276.07
257.85
231.08
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
327.55
276.07
257.85
231.08
Raw Material Cost
0.00
0.00
0.00
0.00
Purchase of Finished goods
4.63
6.57
6.12
4.36
(Increase) / Decrease In Stocks
21.65
61.74
45.78
34.71
Employee Cost
19.98
15.67
15.09
12.52
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
130.65
67.07
75.09
69.29
Selling and Distribution Expenses
91.63
73.17
64.44
61.25
Other Expenses
14.62
10.50
9.54
9.75
Total Expenditure (Excl Depreciation)
283.16
234.72
216.06
191.88
Operating Profit (PBDIT) excl Other Income
44.39
41.35
41.79
39.20
Other Income
3.70
0.21
0.18
0.24
Operating Profit (PBDIT)
48.09
41.56
41.97
39.44
Interest
6.85
5.22
5.20
5.63
Exceptional Items
2.06
0.00
0.00
0.00
Gross Profit (PBDT)
43.30
36.34
36.77
33.81
Depreciation
1.96
1.65
1.52
1.35
Profit Before Tax
41.34
34.69
35.25
32.45
Tax
1.30
0.22
0.57
0.23
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
40.03
34.47
34.68
32.23
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
40.03
34.47
34.68
32.23
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.03
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
40.03
34.47
34.71
32.23
Equity Capital
19.00
19.00
19.00
19.00
Face Value
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
555.19
Earnings per share (EPS)
21.07
18.14
18.27
16.96
Diluted Earnings per share
20.98
18.01
18.7
16.96
Operating Profit Margin (Excl OI)
13.55%
14.98%
16.21%
16.96%
Gross Profit Margin
13.22%
13.16%
14.26%
14.63%
PAT Margin
12.22%
12.49%
13.45%
13.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 18.65% vs 7.07% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 16.13% vs -0.69% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 7.35% vs -1.05% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 31.23% vs 0.38% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has fallen from Sep 2024

Compare Half Yearly Results Of Nath Bio-Genes With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
327.55
0
327.55
Other Operating Income
0.00
0.00
0.00
Total Operating income
327.55
0
327.55
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
4.63
0
4.63
(Increase) / Decrease In Stocks
21.65
0
21.65
Employee Cost
19.98
0
19.98
Power Cost
0.00
0
0.00
Manufacturing Expenses
130.65
0
130.65
Selling and Distribution Expenses
91.63
0
91.63
Other Expenses
14.62
0.00
14.62
Total Expenditure (Excl Depreciation)
283.16
0
283.16
Operating Profit (PBDIT) excl Other Income
44.39
0.00
44.39
Other Income
3.70
0
3.70
Operating Profit (PBDIT)
48.09
0
48.09
Interest
6.85
0
6.85
Exceptional Items
2.06
0
2.06
Gross Profit (PBDT)
43.30
0
43.30
Depreciation
1.96
0
1.96
Profit Before Tax
41.34
0
41.34
Tax
1.30
0
1.30
Provisions and contingencies
0.00
0
0.00
Profit After Tax
40.03
0
40.03
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
40.03
0
40.03
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
40.03
0
40.03
Equity Capital
19.00
0
19.00
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
21.07
0
21.07
Diluted Earnings per share
20.98
0
20.98
Operating Profit Margin (Excl OI)
13.55%
0%
0.00
13.55%
Gross Profit Margin
13.22%
0%
0.00
13.22%
PAT Margin
12.22%
0%
0.00
12.22%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 327.55 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 18.65% vs 7.07% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 40.03 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 16.13% vs -0.69% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 44.39 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 7.35% vs -1.05% in Sep 2024

Half Yearly - Interest
Interest 6.85 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 31.23% vs 0.38% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.55%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has fallen from Sep 2024